Article Details
Retrieved on: 2024-11-14 10:46:03
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Armata Pharmaceuticals' focus on developing bacteriophage-based therapies for antibiotic-resistant infections, like those caused by Staphylococcus aureus and Pseudomonas aeruginosa, relevant to the tags of antimicrobial resistance and phage therapy.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here